As we have seen previously (see this link), among men with Gleason 9 or 10 disease, brachy boost therapy (BBT) provided better oncological outcomes compared to either radical prostatectomy (RP) alone or external beam radiation therapy (EBRT) alone. The oncological outcomes in that study by Kishan et al. were 10-year metastasis-free survival and 10-year prostate […]
↧
